CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 250 enrolled
Drug / intervention
Permethrin Solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06396507
NCT06396507Phase 3Completed

Comparing Sulfur to Different Regimes of Permethrin for the Treatment of Scabies

Damascus University·interventional·Posted May 2, 2024·Updated May 2, 2024

In Brief

A Phase 3 clinical trial evaluating Permethrin Solution and Sulfur for Scabies. Completed, enrolled 250 participants across 3 sites.

Detailed Summary

In 2017, the World Health Organization (WHO) labeled scabies as a neglected tropical disease. It is a serious health problem especially in poor developing countries like Syria, where overcrowding, poverty, and war consequences are considered major factors for spreading the disease. Permethrin lotion or cream is the treatment of choice for scabies, and it is applied once a week for two consecutive weeks according to the global guidelines. However, most practitioners in Syria do not adhere to this standard regimen, and a variety of regimens are used instead based mostly on clinical experience. In this study, the investigators are comparing four different regimens of permethrin application and comparing Sulfur to permethrin in terms of efficacy and safety.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsScabies
CountriesSyria

Timeline

Phase 3CompletedFinished
2023202420252026
First PostedMay 2, 2024
Enrollment StartMar 15, 2022
Primary CompletionSep 15, 2022
Study CompletionNov 12, 2022
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 2.2 years ago

Interventions

Permethrin Solutiondrug

permethrin 5 % solution

Sulfurdrug

Sulfur 10%+ vaseline 90 % ointment